The role of the molecular circadian clock in human energy homeostasis

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

The role of the molecular circadian clock in human energy homeostasis. / Dollet, Lucile; Pendergrast, Logan A.; Zierath, Juleen R.

In: Current Opinion in Lipidology, Vol. 32, No. 1, 2021, p. 16-23.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Dollet, L, Pendergrast, LA & Zierath, JR 2021, 'The role of the molecular circadian clock in human energy homeostasis', Current Opinion in Lipidology, vol. 32, no. 1, pp. 16-23. https://doi.org/10.1097/MOL.0000000000000722

APA

Dollet, L., Pendergrast, L. A., & Zierath, J. R. (2021). The role of the molecular circadian clock in human energy homeostasis. Current Opinion in Lipidology, 32(1), 16-23. https://doi.org/10.1097/MOL.0000000000000722

Vancouver

Dollet L, Pendergrast LA, Zierath JR. The role of the molecular circadian clock in human energy homeostasis. Current Opinion in Lipidology. 2021;32(1):16-23. https://doi.org/10.1097/MOL.0000000000000722

Author

Dollet, Lucile ; Pendergrast, Logan A. ; Zierath, Juleen R. / The role of the molecular circadian clock in human energy homeostasis. In: Current Opinion in Lipidology. 2021 ; Vol. 32, No. 1. pp. 16-23.

Bibtex

@article{3a8684b047f443d69a9f362deb0e62f0,
title = "The role of the molecular circadian clock in human energy homeostasis",
abstract = "PURPOSE OF REVIEW: The aim of this review is to present the latest findings on the role of the circadian clock in the control of metabolism, and the therapeutic potential of chronotherapy to regulate energy homeostasis in humans. RECENT FINDINGS: We summarized the recent advances related to circadian clock regulation of food intake and energy expenditure. In peripheral organs, mitochondrial oxidative capacity and lipolysis show circadian pattern in humans, and rhythms disruption may be involved in the pathogenesis of metabolic diseases. Indeed, circadian desynchrony affects food intake, insulin sensitivity, and increases the risk of developing metabolic disease. Time-targeted strategies, which aim to synchronize external cues with the molecular clock to improve metabolic outcomes, have positive effects on metabolism in humans, with several studies showing that time-targeted feeding improves body weight loss and glucose tolerance. SUMMARY: The interest in time-targeted strategies to prevent or manage metabolic disturbances has grown this past year with encouraging health benefits. To maximize the therapeutic effect of these strategies, further research is warranted to delineate the molecular regulation of metabolic processes controlled by the clock and especially its modulation in contexts such as aging, sex differences, or metabolic diseases.",
author = "Lucile Dollet and Pendergrast, {Logan A.} and Zierath, {Juleen R.}",
year = "2021",
doi = "10.1097/MOL.0000000000000722",
language = "English",
volume = "32",
pages = "16--23",
journal = "Current Opinion in Lipidology",
issn = "0957-9672",
publisher = "Lippincott Williams & Wilkins, Ltd.",
number = "1",

}

RIS

TY - JOUR

T1 - The role of the molecular circadian clock in human energy homeostasis

AU - Dollet, Lucile

AU - Pendergrast, Logan A.

AU - Zierath, Juleen R.

PY - 2021

Y1 - 2021

N2 - PURPOSE OF REVIEW: The aim of this review is to present the latest findings on the role of the circadian clock in the control of metabolism, and the therapeutic potential of chronotherapy to regulate energy homeostasis in humans. RECENT FINDINGS: We summarized the recent advances related to circadian clock regulation of food intake and energy expenditure. In peripheral organs, mitochondrial oxidative capacity and lipolysis show circadian pattern in humans, and rhythms disruption may be involved in the pathogenesis of metabolic diseases. Indeed, circadian desynchrony affects food intake, insulin sensitivity, and increases the risk of developing metabolic disease. Time-targeted strategies, which aim to synchronize external cues with the molecular clock to improve metabolic outcomes, have positive effects on metabolism in humans, with several studies showing that time-targeted feeding improves body weight loss and glucose tolerance. SUMMARY: The interest in time-targeted strategies to prevent or manage metabolic disturbances has grown this past year with encouraging health benefits. To maximize the therapeutic effect of these strategies, further research is warranted to delineate the molecular regulation of metabolic processes controlled by the clock and especially its modulation in contexts such as aging, sex differences, or metabolic diseases.

AB - PURPOSE OF REVIEW: The aim of this review is to present the latest findings on the role of the circadian clock in the control of metabolism, and the therapeutic potential of chronotherapy to regulate energy homeostasis in humans. RECENT FINDINGS: We summarized the recent advances related to circadian clock regulation of food intake and energy expenditure. In peripheral organs, mitochondrial oxidative capacity and lipolysis show circadian pattern in humans, and rhythms disruption may be involved in the pathogenesis of metabolic diseases. Indeed, circadian desynchrony affects food intake, insulin sensitivity, and increases the risk of developing metabolic disease. Time-targeted strategies, which aim to synchronize external cues with the molecular clock to improve metabolic outcomes, have positive effects on metabolism in humans, with several studies showing that time-targeted feeding improves body weight loss and glucose tolerance. SUMMARY: The interest in time-targeted strategies to prevent or manage metabolic disturbances has grown this past year with encouraging health benefits. To maximize the therapeutic effect of these strategies, further research is warranted to delineate the molecular regulation of metabolic processes controlled by the clock and especially its modulation in contexts such as aging, sex differences, or metabolic diseases.

U2 - 10.1097/MOL.0000000000000722

DO - 10.1097/MOL.0000000000000722

M3 - Journal article

C2 - 33278080

AN - SCOPUS:85099114054

VL - 32

SP - 16

EP - 23

JO - Current Opinion in Lipidology

JF - Current Opinion in Lipidology

SN - 0957-9672

IS - 1

ER -

ID: 272643208